Episodios

  • S2 Ep16: Food Fight - Drs Treat and Oza Debate Eczema Triggers

    S2 Ep16: Food Fight - Drs Treat and Oza Debate Eczema Triggers
    Jul 14 2024
    In today’s episode, Drs Vikash Oza, MD, and James Treat, MD, delve into the topic, “Does Food Trigger Eczema?” Oza, an associate professor of dermatology and pediatrics and the director of pediatric dermatology at NYU in New York City, and Treat, a professor of clinical pediatrics and dermatology at the Perelman School of Medicine and an affiliate of the Children’s Hospital of Philadelphia, participated in 1 of 3 “Great Debates in Peds Derm” at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. The duo shared insights from their debate and pearls for clinicians related to allergy and eczema.
    Más Menos
    14 m
  • S2 Ep15: Navigating Artificial Intelligence in Medicine Featuring Albert Yan, MD, FAAP, FAAD

    S2 Ep15: Navigating Artificial Intelligence in Medicine Featuring Albert Yan, MD, FAAP, FAAD
    Jul 12 2024
    In today’s episode, Albert Yan, MD, FAAP, FAAD, research director at the Children's Hospital of Philadelphia, professor at the Perelman School of Medicine, and executive at Inner Archways LLC, discusses pearls and insights from his lecture presented at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. Yan spoke on artificial intelligence and ChatGPT and the balance of positive yet harmful potential of AI chatbots in medicine.
    Más Menos
    12 m
  • S2 Ep14: Navigating Systemic Therapies in Atopic Dermatitis

    S2 Ep14: Navigating Systemic Therapies in Atopic Dermatitis
    Jul 1 2024
    James Song, MD, FAAD, chief medical officer and director of clinical research at Frontier Dermatology in Seattle, Washington, delves into the complexities and advancements in treating atopic dermatitis (AD). Song highlights the challenges of transitioning patients from topical to systemic therapies, emphasizing the need for timely conversations and patient comfort. He discusses the efficacy and rapid response of oral JAK inhibitors compared to biologics, while addressing safety concerns and the necessity for blood monitoring. Song also explores patient-specific factors in treatment choices, the importance of systemic therapy for moderate to severe cases, and the promise of emerging biologics targeting IL-31 and OX40 pathways. This episode is a comprehensive guide for dermatology clinicians navigating the evolving landscape of AD treatments.
    Más Menos
    6 m
  • S2 Ep13: Enhancing Vitiligo Care With Nanette Silverberg, MD

    S2 Ep13: Enhancing Vitiligo Care With Nanette Silverberg, MD
    Jun 25 2024
    In today’s episode, Nanette Silverberg reviews the key highlights from her vitiligo sessions at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, also known this year as RAVE. Dr. Silverberg is the chief of pediatric dermatology for the Mount Sinai Health System and site director of pediatric and adolescent dermatology at Mount Sinai West and Mount Sinai Beth Israel in New York, as well as the conference chair of the vitiligo portion of RAVE. At the conference, Dr. Silverberg presented “Topical Therapeutics for Vitiligo” and “Excellence in Vitiligo Clinical Practice.” Today, Dr. Silverberg shares the top takeaways from her sessions that clinicians can utilize in their practice.
    Más Menos
    11 m
  • S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

    S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story
    Jun 4 2024
    Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.
    Más Menos
    19 m
  • S2 Ep11: A Reminder of Patient Impact

    S2 Ep11: A Reminder of Patient Impact
    May 7 2024
    Brian Kim, MD, had an unexpected attendee at one of his AAD sessions and delves into what's new, what's now, and what's next in atopic dermatitis management.
    Más Menos
    6 m
  • S2 Ep10: Make Data-Driven Decisions For Personalized AD Treatment

    S2 Ep10: Make Data-Driven Decisions For Personalized AD Treatment
    Apr 8 2024
    Christopher Bunick, MD, PhD, associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut and Dermatology Times Editorial Advisory Board Member, caught up with us at the 2024 American Academy of Dermatology Meeting to decode new atopic dermatitis treatment data and how that translates to personalized options for patients.
    Más Menos
    10 m
  • S2 Ep9: Decoding Atopic Dermatitis at AAD

    S2 Ep9: Decoding Atopic Dermatitis at AAD
    Mar 4 2024
    Raj Chovatiya, MD, PhD, gives a sneak peek of what to expect in atopic dermatitis education at the 2024 American Academy of Dermatology (AAD) Meeting in San Diego, California March 8-12. Since the last meeting, the AAD has released new guidelines to treat the condition.
    Más Menos
    6 m